FDA Approves Edwards EVOQUE Tricuspid Valve Replacement System
The US Food & Drug Administration (FDA) recently approved the Edwards EVOQUE Tricuspid Valve Replacement System – P230013.
The US Food & Drug Administration (FDA) recently approved the Edwards EVOQUE Tricuspid Valve Replacement System – P230013.
Abstract:We report a case of native valve and pacemaker endocarditis in a 78-year-old male with diabetes mellitus who died after cardiac surgery. At autopsy, tricuspid valve vegetations and lung abscesses containing thick, hyaline, septate, and branching hyphae were present. The culture identified Scedosporium apiospermum, an infrequent cause of opportunistic infections…
Membership grants access to journals, courses and a slew of premium benefits.
Please consider supporting us by choosing an option below:
View Membership Options Make A Tax-Deductable Donation
No Thanks, take me to the site and don't show me this again.